Encompass Health Corporation (ehc)
EHC — Company Overview
Encompass Health Corporation (EHC) trades on NYQ as part of the Healthcare peer group (Medical Care Facilities).
| Ticker | EHC |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Exchange | NYQ |
| Market cap | $12.06B |
| Last price | $122.21 |
| Size category | Large Cap |
EHC — Business Description
EHC represents a Medical Care Facilities business in the Healthcare segment. Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, manage…
Official website: https://www.encompasshealth.com.
EHC — Investment Thesis
At a high level, EHC offers exposure to Healthcare with metrics outlined below from public market data.
- Revenue is expanding at roughly 9.6% year-over-year (public data).
- Trailing P/E of 20.40× sits in a moderate band relative to high-growth peers.
- Forward P/E (18.30×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 0.7% adds an income component to total return.
- Equity market capitalization is approximately $12.06B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
EHC — Financial Health
Key financial health indicators for Encompass Health Corporation are derived exclusively from public data — no proprietary estimates.
Profit margin near 10.0% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $229.92M supports balance-sheet flexibility.
| Trailing P/E | 20.40× |
| Forward P/E | 18.30× |
| Price / Sales | 1.94× |
| Price / Book | 4.65× |
| Gross margin | 43.9% |
| Operating margin | 18.1% |
| Profit margin | 10.0% |
| Return on equity | 25.0% |
| Debt / Equity | 82.12 |
| Free cash flow | $229.92M |
EHC — Growth Outlook
Growth outlook for Encompass Health Corporation (EHC) depends on demand trends in Medical Care Facilities and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 9.6% suggests steady but measured expansion.
- Earnings growth of 10.8% year-over-year supports improving profitability.
- Price is 4.5% below the 52-week high.
EHC — Competitive Position
Encompass Health Corporation (EHC) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Care Facilities.
- Market capitalization of $12.06B places EHC among large-cap peers.
- Gross margin near 43.9% may reflect pricing power or favorable mix.
EHC — Strengths
Strengths for Encompass Health Corporation (EHC) inferred from public financial metrics:
- Revenue growth of 9.6% year-over-year.
- Earnings growth of 10.8% year-over-year.
- Return on equity near 25.0% — efficient use of shareholder capital.
- Gross margin of 43.9% supports competitive unit economics.
- Positive free cash flow ($229.92M).
- Large Cap scale ($12.06B) may provide distribution and funding advantages.
EHC — Weaknesses
Weaknesses and pressure points for Encompass Health Corporation (EHC) based on available data:
Insufficient public data to assess this factor.
EHC — Opportunities
- Sustained revenue growth (9.6%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
EHC — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
EHC — Summary
Encompass Health Corporation (EHC) is a large-cap Healthcare company focused on Medical Care Facilities, listed on NYQ. Last price $122.21 with market cap $12.06B. Trailing P/E 20.40×. Revenue grew 9.6% year-over-year per public data. Notable strengths include revenue growth of 9.6% year-over-year. Premium Terminal tools for Encompass Health Corporation add ownership analytics, news, and richer estimate history beyond this public summary.
Start Free — open EHC in Vest Terminal
Access live data, filings, ownership, and analysis for Encompass Health Corporation.
Encompass Health Corporation FAQ
What does Encompass Health Corporation (EHC) do?
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and…
What is EHC's P/E ratio?
Encompass Health Corporation has a trailing P/E of 20.40× based on publicly available market data.
Does EHC pay a dividend?
Indicated dividend yield: 0.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is EHC in?
Encompass Health Corporation is classified in Healthcare (Medical Care Facilities) on NYQ.
What is EHC's market capitalization?
Approximate market cap: $12.06B.
What are the main risks for EHC?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of EHC?
Potential positives include revenue growth of 9.6% year-over-year, earnings growth of 10.8% year-over-year.
Where can I get analyst estimates for EHC?
Public analyst price targets and consensus for Encompass Health Corporation are on the free /stocks/ehc/estimates page. Deeper estimate history and models are available in Vest Terminal.